acetylator

acetylator

 [ah-set″ĭ-la´ter]
an organism capable of metabolic acetylation. Individuals that differ in their inherited ability to metabolize certain drugs, e.g., isoniazid, are termed fast or slow acetylators.

acetylator

/acet·y·la·tor/ (ah-set´ĭ-la″ter) an organism capable of metabolic acetylation; in humans, acetylator status (fast or slow) is determined by the rate of acetylation of sulfamethazine.

acetylator

an organism capable of metabolic acetylation. Those animals that differ in their inherited ability to metabolize certain drugs, e.g. isoniazid, are termed fast or slow acetylators.
References in periodicals archive ?
Accordingly, genotype analysis is indispensable to determine acetylator status rather than, or as a supplement to phenotyping.
Caffeine acetylator phenotyping during maturation in infants.
5B slow acetylator phenotypes, compared with the other ethnic subgroups.
2000b) predicted bladder cancer risk for smokers and nonsmokers by acetylator status, designating never-smoker rapid acetylators as the reference category.
The wild-type NAT2*4 allele is associated with the rapid acetylator phenotype and does not have any nucleotide substitutions.
1) reported an excess of N-acetyltransferase 2 (NAT2) slow-acetylation alleles and, consequently, an excess of slow acetylator genotypes in long-term survivors of this syndrome when they were compared to a group of "friends" (i.
The fast acetylator phenotype occurs in 10-20% of Asians; 50% of Americans (blacks and whites); and 60-70% of Northern Europeans (39, 40).
The slow and fast acetylator phenotypes have been associated with increased risk for cancers of the bladder and colon, respectively.
65) recently reported a lethal wasting disease in A/J mice treated with oleylanilide The disease observed in A/J mice, a slow acetylator strain, paralleled some of the human TOS disease features, whereas their homologous C57BL/6 strain (a fast acetylator) had no symptoms.
Polymorphism in NAT-2 results in the rapid or slow acetylator phenotype, which has been implicated in host susceptibility to liver damage by drugs such as isoniazid [71, 72].
h) Distinction was not possible between these 2 haplotypes, but predicted to represent a fast acetylator.
9) The authors identify several risk factors for the development of hydralazine-induced lupus including high daily doses, slow acetylator and HLA-DRw4 phenotypes, therapy greater than 3 months, and female gender.